Caglar Yusuf Sukru, Buyuktepe Murat, Sayaci Emre Yagiz, Dogan Ihsan, Bozkurt Melih, Peker Elif, Soydal Cigdem, Ozkan Elgin, Kucuk Nuriye Ozlem
Department of Neurosurgery, Ankara University School of Medicine, 06230 Ankara, Turkey.
Department of Neurosurgery, Unye State Hospital, 05230 Ordu, Turkey.
Diagnostics (Basel). 2024 Jul 18;14(14):1551. doi: 10.3390/diagnostics14141551.
In this case series, we aimed to report our clinical experience with hybrid positron emission tomography (PET) and magnetic resonance imaging (MRI) navigation in the management of recurrent glial brain tumors. Consecutive recurrent neuroglial brain tumor patients who underwent PET/MRI at preoperative or intraoperative periods were included, whereas patients with non-glial intracranial tumors including metastasis, lymphoma and meningioma were excluded from the study. A total of eight patients (mean age 50.1 ± 11.0 years) with suspicion of recurrent glioma tumor were evaluated. Gross total tumor resection of the PET/MRI-positive area was achieved in seven patients, whereas one patient was diagnosed with radiation necrosis, and surgery was avoided. All patients survived at 1-year follow-up. Five (71.4%) of the recurrent patients remained free of recurrence for the entire follow-up period. Two patients with glioblastoma had tumor recurrence at the postoperative sixth and eighth months. According to our results, hybrid PET/MRI provides reliable and accurate information to distinguish recurrent glial tumor from radiation necrosis. With the help of this differential diagnosis, hybrid imaging may provide the gross total resection of recurrent tumors without harming eloquent brain areas.
在本病例系列中,我们旨在报告我们在复发性胶质脑肿瘤管理中使用正电子发射断层扫描(PET)与磁共振成像(MRI)联合导航的临床经验。纳入了在术前或术中接受PET/MRI检查的连续性复发性神经胶质脑肿瘤患者,而包括转移瘤、淋巴瘤和脑膜瘤在内的非胶质颅内肿瘤患者被排除在研究之外。共有8例疑似复发性胶质瘤的患者(平均年龄50.1±11.0岁)接受了评估。7例患者实现了PET/MRI阳性区域的肿瘤全切除,而1例患者被诊断为放射性坏死,未进行手术。所有患者在1年随访时均存活。5例(71.4%)复发性患者在整个随访期内无复发。2例胶质母细胞瘤患者分别在术后第6个月和第8个月出现肿瘤复发。根据我们的结果,PET/MRI联合成像能提供可靠且准确的信息,以区分复发性胶质肿瘤与放射性坏死。借助这种鉴别诊断,联合成像可在不损害脑功能区的情况下实现复发性肿瘤的全切除。